Check it out: pharmaceuticals company aims to regulate aging.
Elixir Pharmaceuticals is a private company that aims to not only extend the expected lifetime (by up to as much as 30%), but also to regulate aging related diseases.

Receiving their first investments in 2000, Dr. Cindy Bayley, along with Dr. Leonard Guarente, Dr. Cynthia Kenyon, and other leading researchers began their search for the key to aging. In the 6 years that have passed, they have discovered not only the chromosome location of the genes related to a long life, but also a new treatment for Type II Diabetes.

Elixir continues to stay at the top of the newly emerging biotechnology field, as well as leading the pack in aging related research.

More on Dr. Leonard Guarente and the search / benefits of anti-aging technology can be heard on Futures in Biotech on the twit.tv network.